The results of a new study, published in the Lancet eClinical Medicine, showed that an experimental drug (AXA1125) significantly reduces fatigue in people with Long COVID. Scientists who carried out the small-scale clinical trial believe this drug may increase energy production in cells and reduce inflammation for people fighting the virus and its aftereffects.
![](https://longcovidproject.eu/wp-content/uploads/2022/09/timon-studler-ABGaVhJxwDQ-unsplash.jpg)
Hope for long COVID treatment breakthrough after study’s ‘really positive’ findings
- Post date 14. April 2023
- Post categories In news
- Tags news